2026 NPPES data Plastic Surgery within the Head & Neck (Otolaryngology) Physician NPI 1235292855 M.D.
Verify on CMS →

GEORGE BRAUN, M.D.

Plastic Surgery within the Head & Neck (Otolaryngology) Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 505 beneficiaries · Plastic Surgery within the Head & Neck (Otolaryngology) Physician avg: 379
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$126.01
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GEORGE BRAUN, M.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 1,838 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
2K
Part D claims, 2023
97%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GEORGE BRAUN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GEORGE BRAUN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GEORGE BRAUN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 12/18/2006

NPI 1235292855

Primary specialty

Plastic Surgery within the Head & Neck (Otolaryngology) Physician

Niche

608 US NPIs in this specialty

Medicare Part D claims

1,838 385% vs specialty avg

2023 prescription claims

Specialty avg: 379

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Plastic Surgery within the Head & Neck (Otolaryngology) Physician compares to other specialties among New York providers

New York providers

Plastic Surgery within the Head & Neck (Otolaryngology) Physician share within New York

1. Plastic Surgery within the Head & Neck (Otolaryngology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Plastic Surgery within the Head & Neck (Otolaryngology) Physician share within New York

Medicare quality performance — MIPS

GEORGE BRAUN, M.D.'s 2023 MIPS final score plotted against the Plastic Surgery within the Head & Neck (Otolaryngology) Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Plastic Surgery within the Head & Neck (Otolaryngology) Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Plastic Surgery within the Head & Neck (Otolaryngology) Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GEORGE BRAUN, M.D. appears in the CMS NPPES registry as a Plastic Surgery within the Head & Neck (Otolaryngology) Physician provider holding M.D. credentials at 38 E 38TH ST, NEW YORK, NY, 10016, with a listed phone of (212) 685-4430. NPI 1235292855 was issued on 12/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRAUN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,838 prescription claims written by this provider, covering 505 Medicare beneficiaries and totaling roughly $66K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.

Plastic Surgery within the Head & Neck (Otolaryngology) Physician is a narrow specialty nationwide, with 608 enrolled providers across 48 states and an average of 379 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

38 E 38TH ST
NEW YORK, NY 10016

Provider Details

NPI 1235292855
Specialty Plastic Surgery within the Head & Neck (Otolaryngology) Physician
Credentials M.D.
Gender Male
NPI Issued 12/18/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GEORGE BRAUN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$126

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to GEORGE BRAUN, M.D.. To verify GEORGE BRAUN, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

GEORGE BRAUN, M.D. — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 1,838 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,838
Total Claims
$66K
Total Drug Cost
505
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,180
Total Day Supply
53,910
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$10K
Generic Drug Cost
$55K
Antibiotic Claims
255

Patient Demographics

Average Patient Age
74.7 years
Avg HCC Risk Score
1.13
Gender Split
64% female / 36% male
Age Distribution
<65: 18, 65-74: 240, 75-84: 196, 85+: 51

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GEORGE BRAUN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Azelastine Hcl
725
Neomycin-Polymyxin-Hydrocort
Neomycin/Polymyxin B/Hydrocort
135
Mometasone Furoate
130
Cefdinir
105
Meclizine Hcl
76
Montelukast Sodium
70
Azithromycin
64
Desloratadine
61
Fluticasone Propionate
50
Ciprofloxacin-Dexamethasone
Ciprofloxacin Hcl/Dexameth
44

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Plastic Surgery within the Head & Neck (Otolaryngology) Physician Overview

How GEORGE BRAUN, M.D. fits within the Plastic Surgery within the Head & Neck (Otolaryngology) Physician landscape nationally.

608
Plastic Surgery within the Head & Neck (Otolaryngology) Physician Providers in US
48
States with Plastic Surgery within the Head & Neck (Otolaryngology) Physician
379
Avg Claims per Provider

GEORGE BRAUN, M.D.'s 1,838 claims are above the specialty average of 379.

Nearby Plastic Surgery within the Head & Neck (Otolaryngology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BRAUN.

Compare Plastic Surgery within the Head & Neck (Otolaryngology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GEORGE BRAUN, M.D.'s specialty?
GEORGE BRAUN, M.D. specializes in Plastic Surgery within the Head & Neck (Otolaryngology) Physician and practices in NEW YORK, New York. Credentials: M.D..
How much does GEORGE BRAUN, M.D. prescribe under Medicare Part D?
In 2023, GEORGE BRAUN, M.D. wrote 1,838 Medicare Part D claims totaling $66K in drug costs for 505 beneficiaries.
What is GEORGE BRAUN, M.D.'s Medicare quality score?
GEORGE BRAUN, M.D. has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GEORGE BRAUN, M.D. located?
GEORGE BRAUN, M.D. is located at 38 E 38TH ST, NEW YORK, NY, 10016. Phone: (212) 685-4430.
What is GEORGE BRAUN, M.D.'s NPI number?
GEORGE BRAUN, M.D.'s National Provider Identifier (NPI) is 1235292855, issued on 12/18/2006.
Does GEORGE BRAUN, M.D. prescribe more brand-name or generic drugs?
GEORGE BRAUN, M.D.'s prescribing is 3% brand-name and 97% generic drugs by claim count, with $10K in brand drug costs.
How many Plastic Surgery within the Head & Neck (Otolaryngology) Physician providers are there in the US?
There are 608 Plastic Surgery within the Head & Neck (Otolaryngology) Physician providers across 48 states in the US. The average Plastic Surgery within the Head & Neck (Otolaryngology) Physician provider writes 379 Medicare Part D claims per year.
What drugs does GEORGE BRAUN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, GEORGE BRAUN, M.D.'s most frequently prescribed drugs include Azelastine Hcl, Neomycin-Polymyxin-Hydrocort, Mometasone Furoate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GEORGE BRAUN, M.D. accept Medicare?
GEORGE BRAUN, M.D. appears in CMS Medicare data with 1,838 Part D claims and 505 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GEORGE BRAUN, M.D.'s credentials?
GEORGE BRAUN, M.D.'s NPI is 1235292855 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology